At a glance
- Originator Takeda
- Class Hormones
- Mechanism of Action Gonadotropin releasing hormone inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 07 Apr 2003 No development reported - Preclinical for Cancer in Japan (PO)
- 14 Jun 2000 Profile reviewed but no significant changes made
- 17 Feb 1999 New profile